Uganda has received its first consignment of Lenacapavir, a long-acting HIV prevention injection administered twice a year, ...
The Philadelphia HIV Resource Finder allows Philadelphians to search for treatment and prevention resources throughout the city.
Researchers highlighted the anti-inflammatory benefits of GLP-1 receptor agonists in people with HIV, plus a growing concern over rising STI rates and the cautious promise of doxycycline post-exposure ...
A new study led by researchers from the CUNY Institute for Implementation Science in Population Health (ISPH) finds that the ...
Merck Announces Late-Breaking Data from Three Phase 3 Trials Evaluating Doravirine/Islatravir (DOR/ISL), a Once-Daily, Two-Drug Regimen at CROI 2026 ...
In 2006, Gilead Sciences and Bristol Myers Squibb left a permanent mark on the HIV treatment paradigm by fusing together three antiretrovirals and creating the ...
Dar es Salaam. Health practitioners in Tanzania are optimistic after the official registration of Lenacapavir, a long-acting ...
Application error: a client-side exception has occurred (see the browser console for more information).
An initial consignment of 19, 200 doses of Lanacapavir, a six-monthly HIV prevention injection drug, has arrived in Uganda, ...
Kenya takes a massive leap in HIV prevention, here is everything you need to know about the Lenacapavir rollout.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results